Regulatory Approach for Biosimilars

This networking meet will provide an excellent opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to discuss and learn about the regulatory competencies required for Biosimilars and Biologics.This track includes: Licensing of biosimilars, Biosimilars regulation, Biosimilar Patents , BLA filing for biosimilars, Regulatory prospects of BRIC countries, a paradigm of traditional generics to biosimilars, Biowaiver approval for Biosimilars. Approximately 20% of the biologics and biosimilars in the worldwide R&D pipelines are facing challenges to fall in line with the regulatory guidelines.

Quick Links

Are you interested in

Copyright © 2017-2018 Allied Academies, All Rights Reserved.